Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers.

MLA

Simon, Thomas, et al. “Inhibition of Effector Antigen-Specific T Cells by Intradermal Administration of Heme Oxygenase-1 Inducers.” Journal of Autoimmunity, vol. 81, July 2017, pp. 44–55. EBSCOhost, https://doi.org/10.1016/j.jaut.2017.03.005.

APA

Simon, T., Pogu, J., Rémy, S., Brau, F., Pogu, S., Maquigneau, M., Fonteneau, J.-F., Poirier, N., Vanhove, B., Blancho, G., Piaggio, E., Anegon, I., & Blancou, P. (2017). Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers. Journal of Autoimmunity, 81, 44–55. https://doi.org/10.1016/j.jaut.2017.03.005

Chicago

Simon, Thomas, Julien Pogu, Séverine Rémy, Frédéric Brau, Sylvie Pogu, Maud Maquigneau, Jean-François Fonteneau, et al. 2017. “Inhibition of Effector Antigen-Specific T Cells by Intradermal Administration of Heme Oxygenase-1 Inducers.” Journal of Autoimmunity 81 (July): 44–55. doi:10.1016/j.jaut.2017.03.005.